Cited by 173Genomics and Rare DiseasesGenomics and Phylogenetic StudiesGenetics, Bioinformatics, and Biomedical Research

Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application

Open access
Lightbody, Gaye, Haberland, Valeriia, Browne, Fiona, Taggart, Laura, Zheng, Huiru, Parkes, Eileen, Blayney, Jaine K·2019·Briefings in Bioinformatics

Abstract

There has been an exponential growth in the performance and output of sequencing technologies (omics data) with full genome sequencing now producing gigabases of reads on a daily basis. These data may hold the promise of personalized medicine, leading to routinely available sequencing tests that can guide patient treatment decisions. In the era of high-throughput sequencing (HTS), computational considerations, data governance and clinical translation are the greatest rate-limiting steps. To ensure that the analysis, management and interpretation of such extensive omics data is exploited to its full potential, key factors, including sample sourcing, technology selection and computational expertise and resources, need to be considered, leading to an integrated set of high-performance tools and systems. This article provides an up-to-date overview of the evolution of HTS and the accompanying tools, infrastructure and data management approaches that are emerging in this space, which, if used within in a multidisciplinary context, may ultimately facilitate the development of personalized medicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/bib/bby051

Cites

208 of 208 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High-throughput omics data has been central to developing precision medicine biomarkers for Alzheimer's, diabetes, cancer, hypertension, cardiovascular and chronic respiratory diseases.

    “High-throughput generated omics data (Lightbody et al., 2019) has played a pivotal role in developing precision medicine biomarkers for diseases such as Alzheimer's (Hampel et al., 2017(Hampel et al., , 2016;;Kovacs, 2016), diabetes (Capobianco, 2017;McCarthy, 2017;Mutie et al., 2017), cancer (Borad and LoRusso, 2017;Senft et al., 2017), hypertension (Barnes et al., 2016;Dominiczak et al., 2017),”

    From Using machine learning approaches for multi-omics data analysis: A review (2021) · cites this paper as Lightbody et al., 2019

  • Such an amount of data poses significant computational challenges, in particular when considering that NGS throughput exponentially increases over the years, and the reduction of sequencing costs per genome outweighs that of the costs of computational power, as described by the Moore's law.

    “Such an amount of data poses significant computational challenges, in particular when considering that NGS throughput exponentially increases over the years, and the reduction of sequencing costs per genome outweighs that of the costs of computational power, as described by the Moore’s law [132].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. [13]Anderson C. Data deluge. Clin OMICS 2017; 4(1): 26– 9.
  2. [178]Wang C, Li X, Zhou X, et al Genome sequencing using mapreduce on FPGA with multiple hardware accelerators. In: Conference: Proceedings of the ACM/SIGDA international symposium on Field programmable gate arrays ACM, 2013, 266.
  3. [183]Carr DA, Paszko C, Kolva D. SeqNFind®: a GPU accelerated sequence analysis toolset facilitates bioinformatics. Nature Methods | Application Notes, 2011, 1– 4. https://www.nature.com/app_notes/nmeth/2011/110908/full/an8037.html
  4. [198]Woods R, McAllister J, Lightbody G, et alFPGA-Based Implementation of Signal Processing Systems West Sussex, UK: Wiley, 2017 https://www.wiley.com/en-us/FPGA+based+Implementation+of+Signal+Processing+Systems%2C+2nd+Edition-p-9781119077954
  5. [228]NCBI. GenBank home. NCBI, 2017 https://www.ncbi.nlm.nih.gov/genbank/
  6. [235]Skloot R. The immortal life of Henrietta Lacks New York, NY: Random House Inc., 2010. p. 384. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898613/

Cited by

Sorted by citations

Authors
Lightbody, G., Haberland, V., Browne, F., Taggart, L., Zheng, H., Parkes, E., & Blayney, J. K.
Affiliations
  • University of Ulster (GB)
  • University of Bristol (GB)
  • Almac (United Kingdom) (GB)
  • Queen's University Belfast (GB)
Corresponding author
Lightbody, Gaye
Venue
Briefings in Bioinformatics
Published
2019-06-14
Volume
20
Issue
5
Pages
1795-1811
ISSN
  • 1467-5463 (ISSN-L)
  • 1477-4054
OpenAlex
W2885591122
Cited by
173
References
208
Citations by year
2026: 11 · 2025: 20 · 2024: 26 · 2023: 27 · 2022: 34 · 2021: 25 · 2020: 21 · 2019: 8 · 2018: 1
FWCI
1.92
Type
journal article
Language
en
Open access
Locations
  • Briefings in Bioinformatics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Brunel University Research Archive (BURA) (Brunel University London) (submittedVersion, cc-by)
  • Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
  • Ulster University Research Portal (Ulster University) (submittedVersion, cc-by)
  • Explore Bristol Research (submittedVersion, cc-by)
  • Bristol Research (University of Bristol) (submittedVersion, cc-by)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
Funders
Academy of Medical Sciences (SGL017\1064)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genetics, Bioinformatics, and Biomedical Research
Keywords
next-generation sequencing, personalized medicine, clinical translation, data governance, computational genomics, genomic data interpretation, bioinformatics infrastructure
MeSH terms
Cloud Computing, Ethics, Computer Security, Computational Biology, Biomedical Research, Precision Medicine, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review